Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic of
respiratory and cardiovascular diseases, known as coronavirus disease 2019 (COVID-19) …

Convalescent plasma (CP) from patients recovered from COVID-19 is one of the most
studied anti-viral therapies against SARS-COV-2 infection. The aim of this study is to …

Transporters in the human liver play a major role in the clearance of endo-and xenobiotics.
Apical (canalicular) transporters extrude compounds to the bile, while basolateral …

The Omicron variant (B. 529) of COVID-19 caused disease outbreaks worldwide because of
its contagious and diverse mutations. To reduce these outbreaks, therapeutic drugs and …

Background: Although several therapeutic strategies have been investigated, the optimal
treatment approach for patients with coronavirus disease (COVID-19) remains to be …

Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced …

Background: In the past few years, COVID-19 became the leading cause of morbidity and
mortality worldwide. Although the World Health Organization has declared an end to COVID …

In Winter 2020, Italy, and in particular the Lombardy region, was the first country in the
Western hemisphere to be hit by the COVID-19 pandemic. Plasma from individuals …

Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …

SARS-CoV-2 (severe acute respiratory syndrome) is highly infectious and causes severe
acute respiratory distress syndrome (SARD), immune suppression, and multi-organ failure …